Company Description
Avigen, Inc.. The Group's principal activity is to develop and commercialize small molecule therapeutics and biologics to treat serious neurological and neuromuscular disorders. The Group product candidates primarily address neuromuscular spasm and ...
More
Related Business Topics
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
A
Avigen
Developer of gene therapy products derived from adeno-associated virus ("AAV") for the treatment of inherited and acquired diseases.
www.avigen.com
Developer of gene therapy products derived from adeno-associated virus ("AAV") for the treatment of inherited and acquired diseases.
www.avigen.com
Breaking News
Reuters - Nov. 12, 2009, 4:17 PM
5:10pm EST storyKeywords RTR_ArticleTitle 'MediciNova Reports Third Quarter 2009 RTR_ArticleBlurb ' SAN DIEGO, Calif., Nov. 12, 2009 (GLOBE NEWSWIRE) MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market ...
